In order to receive credit for this activity, you must read the front matter, view the activity, complete the post-survey, as well as complete the linked evaluation and application for credit form. Certificates of credit will be emailed to participants who have successfully met these requirements.

There is no fee to participate in this activity.

Question Title

* 1. What are your specialty & credentials?

Question Title

* 2. What is your community of practice?

Question Title

* 3. 28 y/o female with Crohn's Colitis, was previously controlled on adalimumab; now with loss of response due to anti-drug antibodies. She also has a history of psoriasis that is now flaring again off adalimumab. She plans to get pregnant in the next 1-2 years.

Which therapy/MOA would be most effective and desirable in this context?

Question Title

* 4. In VIVID-2 extension, what percentage of patients with Crohn’s disease who achieved endoscopic response to Mirikizumab at week 52 maintained that response at year 2?

EVALUATION FORM

Question Title

* 5. Upon completion of this activity, I am able to:

  Strongly agree Agree Disagree Strongly disagree
Evaluate the clinical safety and efficacy data for newly approved and emerging therapies for patients with IBD

Question Title

* 6. Please indicate the extent of your agreement with the following statements:

  Strongly agree Agree Disagree Strongly disagree
The faculty for this activity were effective

Question Title

* 7. Overall, was this activity fair, balanced and free from commercial bias?

Question Title

* 8. If no, please explain:

Question Title

* 9. Of the patients with IBD you will see in the next month, about how many will benefit from the information you learned today?

Question Title

* 10. Based on what I learned today, I will improve my practice by incorporating the following for my patients with IBD (check all that apply):

Question Title

* 11. Based on your experience, which of the following are the primary barriers to implementing changes in practice (check all that apply):

Question Title

* 12. For purposes of certification, you must complete the following information.
*Please note that we will not forward or sell your contact information.*

Question Title

* 13. I certify that I have participated in the continuing education activity entitled, "MondayNightIBD | IL-23p19 agents in Crohn's Disease Expert Video" and claim 0.5 AMA PRA Category 1 CreditTM.

Thank you for participating in our activity and completing the necessary paperwork. Your certificate will be emailed to you using the email address provided above. Please allow 4 weeks to receive your certificate.

For additional information about the accreditation of this activity, please visit https://www.partnersed.com